Use this url to cite publication: https://hdl.handle.net/20.500.12512/23692
Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL trial
Type of publication
Straipsnis Web of Science duomenų bazėje / Article in Web of Science database (S1a)
Author(s)
| Author | Affiliation | |
|---|---|---|
Bethel, M Angelyn | Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK | |
Mentz, Robert J. | Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA | |
Merrill, Peter | Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA | |
Buse, John B. | Division of Endocrinology, University of North Carolina School of Medicine, USA | |
Chan, Juliana C. | Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, China | |
Goodman, Shaun G. | St. Michaels Hospital, University of Toronto, Ontario, Canada | Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada |
Iqbal, Nayyar | AstraZeneca Research and Development, Gaithersburg, USA | |
Katona, Brian | AstraZeneca Research and Development, Gaithersburg, USA | |
Lokhnygina, Yuliya | Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA | |
Lopes, Renato D. | Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA | |
Maggioni, Aldo P. | ANMCO Research Center, Florence, Italy | |
Ohman, Peter | AstraZeneca Research and Development, Gaithersburg, USA | |
Tankova, Tsvetalina | Clinical Center of Endocrinology, Medical University, Sofia, Bulgaria | |
Bakris, George L. | Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, USA | |
Hernandez, Adrian F. | Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA | |
Holman, Rury R. | Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK |
Title
Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL trial
M. Angelyn Bethel, Robert J. Mentz, Peter Merrill, John B. Buse, Juliana C. Chan, Shaun G. Goodman, Nayyar Iqbal, Neli Jakuboniene, Brian Katona, Yuliya Lokhnygina, Renato D. Lopes, Aldo P. Maggioni, Peter Ohman, Tsvetalina Tankova, George L. Bakris, Adrian F. Hernandez, Rury R. Holman
Publisher (trusted)
American Diabetes Association
Is Referenced by
Date Issued
| Date |
|---|
2020-02-01 |
Extent
p. 446-452.
Is part of
Diabetes care. Alexandria : American Diabetes Association, 2020, vol. 43, no. 2.
Version
Originalus / Original
Science / Art Area
Medicinos ir sveikatos mokslai / Medical and health sciences (M)
Field of Science
Medicina / Medicine (M001)
Resource Type (COAR)
TextJournalJournal article
ISSN (of the container)
0149-5992
1935-5548
PMID
31757838
WOS
000508199900036
Other Identifier(s)
(LSMU ALMA)990000997870107106
Coverage Spatial
Jungtinės Amerikos Valstijos / United States of America (US)
Language
Anglų / English (en)
Bibliographic Details
31
Funding(s)
| Name |
|---|
Amylin Pharmaceuticals, Inc., a wholly owned subsidiary of AstraZeneca |
Merck & Company |
AstraZeneca |
GlaxoSmithKline |